The company has a total R&D laboratory area of nearly 10,000 square meters, with chemical pharmaceutical engineering department, pharmaceutical preparation engineering department, new drug quality control department, medical department, AI laboratory, omics laboratory and other departments. It has formed a high-level new drug research team, of which 50% have master’s degrees and 20% have doctoral degrees. The main members of the team have successively received funding from the National Natural Science Foundation, the Provincial Natural Science Foundation, the Provincial High-tech Field Science and Technology Innovation Leading Plan and Changsha Major Projects. The company adheres to the path of independent innovation, and currently many R&D products have entered clinical research or are about to enter the clinical stage.
Focusing on tumors, cardiovascular and cerebrovascular diseases, and geriatric diseases, we use synthetic medicinal chemistry and natural medicinal chemistry as the research basis to search for and discover novel small molecule compounds with clinical application value, and promote the research and development of original drugs.
Build an innovative Chinese medicine research and development model that integrates artificial intelligence and multi-omics technologies, deeply explain the relationship between traditional Chinese medicine theory and modern microscopic factors such as genes, proteins, and cells, and assist in the research and development of new Chinese medicines.
Focus on products with good market prospects and high technical barriers, carry out the development of first-copy drugs, and enrich the product pipeline.
We conduct research and development of pharmaceutical products, health foods, and special medical foods for the purpose of chronic disease conditioning, tumor prevention and treatment, and sub-health management.
Synthesis and separation of small molecule compounds, heterocyclic compounds, chiral compounds, and research and optimization of drug synthesis processes.
Formulation and process studies, dosage form quality studies, process scale-up and technology transfer, analytical method development and stability studies.
Spectroscopic testing, chromatographic testing, mass spectrometry testing, element and impurity determination, physical and chemical and particle size testing.
Laboratory synthesis and small equipment scale-up, and research on feasible industrial solutions based on small-scale experiments.
